PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer

Immune checkpoint inhibition represents a major recent breakthrough in the treatment of malignant diseases including breast cancer. Blocking the programmed death receptor-1 (PD-1) and its ligand, PD-L1, has shown impressive antitumor activity and may lead to durable long-term disease control, especi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Breast Care (Basel)
Hlavní autoři: Hartkopf, Andreas D., Taran, Florin-Andrei, Wallwiener, Markus, Walter, Christina B., Krämer, Bernhard, Grischke, Eva-Maria, Brucker, Sara Y.
Médium: Artigo
Jazyk:Inglês
Vydáno: S. Karger GmbH 2016
Témata:
Review Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5290437/
https://ncbi.nlm.nih.gov/pubmed/28228704
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000453569
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky